As with much of the biopharmaceutical industry, the COVID-19 pandemic has complicated the dynamics between clinical sites and sponsors, particularly in the realm of contract negotiations and payments.
Significant concessions have been made by both sponsors and sites during the pandemic; some will become norms while others will be rolled back or altered to fit within the new clinical development paradigm going forward. Further, sites face cash management challenges as studies and clinical development programs reboot.
There is a clear desire to sustain the time and cost efficiencies achieved to advance COVID-19 vaccine and treatment studies – and leverage them across therapeutic areas – but managing the increasing complexity requires consistency in approach to avoid lengthy delays and site frustrations, and even more coordination and deliberate formalization of processes.
Register for this webinar to hear experts share perspectives from negotiating tens of thousands of agreements per year – and provide guidance on how to control and accelerate negotiations and optimize site payment processes to drive further efficiencies for both sponsors and sites.
Shaun Williams, Vice President, Investigator Management Solutions, Syneos Health
Shaun Williams is currently Vice President, Investigator Management Solutions at Syneos Health. Prior to this, Mr. Williams was the Vice President of Operations at Clinverse Inc. (now Bioclinica Financial Lifecycle Solutions) a technology provider to the clinical research industry. Mr. Williams also worked with Health Decisions, Inc., and Talecris Plasma Resources (now Grifols). Mr. Williams was also previously a partner at ThinSpring, a company specializing in regulatory compliance software, services, and submissions for structured product labeling (SPL), physician’s labeling rule (PLR), etc. Mr. Williams started his career with Baxter Healthcare in various operations and quality roles throughout the world. He holds a Bachelor of Science in Mechanical Engineering from the United States Military Academy at West Point and is a certified Project Management Professional (PMP).Message Presenter
Matthew Roth, MBA, Sr. Director, SSU & Regulatory, Syneos Health
Matthew Roth works in the study start-up (SSU) space at Syneos Health, where he oversees a portfolio of strategic standalone and functional service provider (FSP) engagements. Relying on over a decade of experience in global study start-up, Mr. Roth helps clinical research sponsors of any size and therapeutic focus streamline and accelerate their SSU operations. Mr. Roth holds an MBA in Marketing from Auburn University.Message Presenter
Who Should Attend?
This webinar will be of interest to biopharmaceutical sponsor stakeholders with responsibilities for site contracts delivery, including:
- Contracting Teams
- Legal Staff
- Procurement/Outsourcing Managers
- Clinical Study Managers
What You Will Learn
In this webinar, participants will:
- Understand how the COVID-19 pandemic has impacted the site contract negotiations and site payment functions, and the challenges sponsors face as we move past the pandemic
- Learn best practices for managing complex and evolving contract negotiations and fulfilling site payment needs
- Discover alternative options for achieving seamless, reliable and scalable contract negotiation and payment processes
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 26,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.